Amna Nawaz
@PBSNewsHour·5.3M subscribers·62.2K videos
FDA approves drug for treating pancreatic cancer
Posted
August 27, 2026
Views
10,919
Likes
94
Engagement
0.86%
August 27, 2026
10,919
94
0.86%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
0:41Now PlayingThe FDA approved a landmark new drug Wednesday for pancreatic cancer that can extend survival times for patients with the disease, which is one of the deadliest forms of cancer.
The daily pill will be marketed under the brand name Rasonque. It works by blocking a protein that fuels tumor growth. Researchers found that it roughly doubled life expectancy when compared to chemotherapy from nearly seven months to more than 13 months and comes with fewer severe side effects.
Revolution Medicines, which makes the drug, says it'll have a sticker price of nearly $40,000 a month, but says much of that would be covered by insurance.
Sign up for Here's The Deal with Lisa Desjardins
Subscribe for exclusive content in our newsletters
PBS News podcasts
Stream your PBS favorites with the PBS app
Find more from PBS News at
Subscribe to our YouTube channel
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
